Business Description
OnKure Therapeutics is a drug development company working to create targeted treatments for cancer and other serious diseases. Its main drug in development, OKI-219, is designed to block a specific genetic mutation linked to tumor growth and is currently being tested in early-stage human trials for breast cancer and other solid tumors. Founded in 2011, the company is based in Boulder, Colorado.
